Chronic Graft Versus Host Disease Recruiting Phase 3 Trials for DB09053 (Ibrutinib)

Also known as: Chronic Graft-Versus-Host-Disease / Chronic Graft-Versus-Host Disease / Chronic Graft vs Host Disease / Chronic graft versus host disease / CGVHD / Chronic Graft-vs.-Host Disease / Chronic Graft-Versus Host Disease / Chronic Graft vs. Host Disease / Chronic GVHD / Chronic GVH disease

IndicationStatusPhase
DBCOND0039599 (Chronic Graft Versus Host Disease)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02959944Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHDTreatment